Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. by Rodgers, G, Esposito, S, Principi, N, Gutierrez-Brito, M, Diez-Domingo, J, Pollard, A, Snape, MD, Martinón-Torres, F, Gruber, W, Patterson, S, Thompson, A, Gurtman, A, Paradiso, P, Scott, D

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age by Snape, M, Pollard, A, Voysey, M, Finn, A, Bona, G, Esposito, S, Principi, N, Diez-Domingo, J, Sokal, E, Kieninger, D, Prymula, R, Dull, P, Kohl, I, Barone, M, Wang, H, Toneatto, D

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedu... by Gossger, N, Snape, MD, Yu, L, Finn, A, Bona, G, Esposito, S, Principi, N, Diez-Domingo, J, Sokal, E, Becker, B, Kieninger, D, Prymula, R, Dull, P, Ypma, E, Toneatto, D, Kimura, A, Pollard, A